Antitrust

Since the beginning of Chair Khan’s tenure at the Federal Trade Commission (and in line with President Biden’s aim to curb rising health care costs), the current FTC has committed to bring enforcement actions against health care consolidation and rising prices. Over the past two years the FTC has employed novel competition tools to achieve this purpose, as demonstrated by the Commission’s suit last week against a private equity firm and its related specialty practice—alleging violations of Sections 1 and 2 of the Sherman Act, Section 7 of the Clayton Act and Section 5 of the FTC Act.

Read the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI, including about the Civil Investigative Demand the FTC recently served to ChatGPT developer OpenAI.

Read about Representative Anna Eshoo’s (D-CA-16) CREATE AI Act, and the National Artificial Intelligence Research Resource that this bill would establish.

The accelerating advances in AI have heightened legislative, executive, and regulatory activities focused on its implications. In a series of articles, Mintz and ML Strategies explore the federal government’s actions in this area, such as the national AI strategic plan and upcoming US Senate forums aimed at forging consensus and informing future legislation.